Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes
2008 · Cancer Chemotherapy and Pharmacology · 30 citations
https://doi.org/10.1007/s00280-008-0882-8